Nutrition
Volume 24, Issue 10 , Pages 933-940 , October 2008

Effect of milk tripeptides on blood pressure: A meta-analysis of randomized controlled trials

  • Jia-Ying Xu, M.S.M.

      Affiliations

    • School of Radiation Medicine and Public Health, Soochow University, Suzhou, China
    • ,
  • Li-Qiang Qin, Ph.D.

      Affiliations

    • School of Radiation Medicine and Public Health, Soochow University, Suzhou, China
    • ,
  • Pei-Yu Wang, Ph.D.

      Affiliations

    • Department of Social Medicine and Health Education, School of Public Health, Peking University, Beijing, China
    • ,
  • Wei Li, B.S. Med

      Affiliations

    • School of Radiation Medicine and Public Health, Soochow University, Suzhou, China
    • ,
  • Chun Chang, Ph.D.

      Affiliations

    • Department of Social Medicine and Health Education, School of Public Health, Peking University, Beijing, China
    • Corresponding Author InformationCorresponding author. Tel.: +86-10-8280-2502; fax: +86-10-8280-2002

Received 29 November 2007 ,Accepted 18 April 2008.

References 

  1. Stamler R. Implications of the INTERSALT study. Hypertension. 1991;17(suppl I):16–20
  2. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease (Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context). Lancet. 1990;335:827–838
  3. Asayama K, Ohkubo T, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. Prediction of stroke by self-measurement of blood pressure at home versus casual screening blood pressure measurement in relation to the Joint National Committee 7 classification: the Ohasama study. Stroke. 2004;35:2356–2361
  4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  5. World Health Organization. The world health report 2002: reducing risks to health, promoting healthy life. Geneva: World Health Organization; 2002;
  6. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the New Joint National Committee Guidelines. Arch Intern Med. 2004;164:2126–2134
  7. Sun Z, Zheng L, Wei Y, Li J, Zhang X, Zhang X, et al. The prevalence of prehypertension and hypertension among rural adults in Liaoning province of China. Clin Cardiol. 2007;30:183–187
  8. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296–308
  9. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure (DASH Collaborative Research Group). N Engl J Med. 1997;336:1117–1124
  10. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure (A meta-analysis of randomized controlled trials). Hypertension. 2001;38:1112–1117
  11. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure (A meta-analysis of randomized controlled trials). Hypertension. 2003;42:878–884
  12. Alonso A, Beunza JJ, Delgado-Rodríguez M, Martínez JA, Martínez-González MA. Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr. 2005;82:972–979
  13. Ruidavets JB, Bongard V, Simon C, Dallongeville J, Ducimetiere P, Arveiler D, et al. Independent contribution of dairy products and calcium intake to blood pressure variations at a population level. J Hypertens. 2006;24:671–681
  14. FitzGerald RJ, Murray BA, Walsh DJ. Hypotensive peptides from milk proteins. J Nutr. 2004;134:980S–988S
  15. Jauhiainen T, Korpela R. Milk peptides and blood pressure. J Nutr. 2007;137:825S–829S
  16. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. Purification and characterization of angiotensin I–converting enzyme inhibitors from sour milk. J Dairy Sci. 1995;78:777–783
  17. Nakamura Y, Yamamoto N, Sakai K, Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I–converting enzyme. J Dairy Sci. 1995;78:1253–1257
  18. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H, Nurminen ML. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol. 2001;52:745–754
  19. The Cochrane Collaboration. http://www.cochrane.orgLast accessed March 20, 2008
  20. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1–12
  21. Follmann D, Elliott P, Shu I, Culter J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45:769–773
  22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  24. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr. 2005;24:257–265
  25. Jauhiainen T, Vapaatalo H, Poussa T, Kyronpalo S, Rasmussen M, Korpela R. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens. 2005;18:1600–1605
  26. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M, et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr. 2005;94:84–91
  27. Sano J, Ohki K, Higuchi T, Aihara K, Mizuno S, Kajimoto O, et al. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Med Food. 2005;8:423–430
  28. Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y, et al. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens. 2004;17:701–706
  29. Tuomilehto J, Lindstrom J, Hyyrynen J, Korpela R, Karhunen ML, Mikkola L, et al. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J Hum Hypertens. 2004;18:795–802
  30. Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr. 2003;77:326–330
  31. Seppo L, Kerojoki O, Suomalainen T, Korpela R. The effect of a lactobacillus helveticus LBK-16 H fermented milk on hypertension—a pilot study on humans. Milchwissenschaft. 2002;57:124–127
  32. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr. 1996;64:767–771
  33. Dent MP, O'Hagan S, Braun WH, Schaetti P, Marburger A, Vogel O. A 90-day subchronic toxicity study and reproductive toxicity studies on ACE-inhibiting lactotripeptide. Food Chem Toxicol. 2007;45:1468–1477
  34. Ondetti MA, Cushman DW. Angiotensin-converting enzyme inhibitors: biochemical properties and biological actions. CRC Crit Rev Biochem. 1984;16:381–411
  35. Mizuno S, Nishimura S, Matsuura K, Gotou T, Yamamoto N. Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. J Dairy Sci. 2004;87:3183–3188
  36. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr. 1996;126:3063–3068
  37. Foltz M, Meynen EE, Bianco V, van Platerink C, Koning TM, Kloek J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J Nutr. 2007;137:953–958
  38. Cadee JA, Chang CY, Chen CW, Huang CN, Chen SL, Wang CK. Bovine casein hydrolysate (c12 Peptide) reduces blood pressure in prehypertensive subjects. Am J Hypertens. 2007;20:1–5
  39. Townsend RR, McFadden CB, Ford V, Cadée JA. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am J Hypertens. 2004;17(11, pt 1):1056–1058
  40. Pins JJ, Keenan JM. Effects of whey peptides on cardiovascular disease risk factors. J Clin Hypertens. 2006;8:775–782
  41. Lee YM, Skurk T, Hennig M, Hauner H. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with milk hypertension. Eur J Nutr. 2007;46:21–27
  42. Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M, et al. Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr. 2003;57:490–495
  43. Qin LQ, Xu JY, Wang PY, Kaneko T, Hoshi K, Sato A. Milk concentration is a risk factor for prostate cancer: meta-analysis of case-control studies. Nutr Cancer. 2004;48:22–27

 This work was supported by the National Natural Science Foundation of China (grant 30771808) and the Medical Developmental Foundation of Soochow University (grant EE126712).

PII: S0899-9007(08)00202-5

doi: 10.1016/j.nut.2008.04.004

Nutrition
Volume 24, Issue 10 , Pages 933-940 , October 2008

Article Tools

* Image Usage & Resolution